Editorial Comment on “Clinician- and Geographic-level Variation in Utilization of Sacral Neuromodulation and OnabotulinumtoxinA Injections Among Medicare Beneficiaries With Overactive Bladder”

Posted by author-avatar

Publication date: Available online 19 November 2025

Source: Urology

Author(s): Peter C. Jeppson, Mary A. Nowlen

Read More

Newer
The Long Road to Healthcare Quality Standardization and Optimization in Urology
Older Hybrid catheter ablation and minimally invasive LVAD implantation in a high-risk patient with refractory ventricular tachycardia